Grifols (GIKLY) Net Income towards Common Stockholders (QoQ) (2010 - 2015)

Grifols (GIKLY) Net Income towards Common Stockholders (QoQ) (2010 - 2015) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2015	-8.18%
Sep 30, 2015	105,910.32%
Dec 31, 2014	-379.63%
Sep 30, 2014	106,233.97%
Jun 30, 2014	-99.91%
Mar 31, 2014	145.61%
Dec 31, 2013	-425.63%
Sep 30, 2013	-6.88%
Jun 30, 2013	-0.24%
Mar 31, 2013	146.95%
Dec 31, 2012	-420.53%
Sep 30, 2012	-5.80%
Jun 30, 2012	-4.28%
Mar 31, 2012	250.04%
Dec 31, 2011	-270.12%
Sep 30, 2011	267.76%
Jun 30, 2011	-144.95%
Mar 31, 2011	134.92%
Dec 31, 2010	-433.30%